| Policy Name |
Policy Number |
Posted |
Archived Documents |
| Flow Cytometry |
CPCPLAB001 |
8/22/2022 |
|
| Cervical Cancer Screening |
CPCPLAB002 |
8/22/2022 |
|
| Vitamin D |
CPCPLAB003 |
8/22/2022 |
|
| Hemoglobin A1c |
CPCPLAB004 |
8/22/2022 |
|
| Prostate Biopsies |
CPCPLAB005 |
8/22/2022 |
|
| Prostate Specific Antigen Testing |
CPCPLAB006 |
8/22/2022 |
|
| Preventive Screening in Adults |
CPCPLAB007 |
8/22/2022 |
|
| Diagnostic Testing of Iron Homeostasis & Metabolism |
CPCPLAB008 |
8/22/2022 |
|
| Testosterone Testing |
CPCPLAB009 |
8/22/2022 |
|
| Vitamin B12 and Methylmalonic Acid Testing |
CPCPLAB010 |
8/22/2022 |
|
| ANA/ENA Testing |
CPCPLAB011 |
8/22/2022 |
|
| Pre-Operative Testing |
CPCPLAB012 |
8/22/2022 |
|
| Allergen Testing |
CPCPLAB013 |
8/22/2022 |
|
| Prenatal Screening |
CPCPLAB014 |
8/22/2022 |
|
| Hepatitis C |
CPCPLAB015 |
8/22/2022 |
|
| Pediatric Preventive Screening |
CPCPLAB016 |
8/22/2022 |
|
| Celiac Disease Testing |
CPCPLAB017 |
8/22/2022 |
|
| Helicobacter Pylori Testing |
CPCPLAB018 |
8/22/2022 |
|
| Thyroid Disease Testing |
CPCPLAB019 |
8/22/2022 |
|
| Cardiovascular Disease Risk Assessment |
CPCPLAB020 |
8/22/2022 |
|
| Prenatal Screening for Fetal Aneuploidy |
CPCPLAB022 |
8/22/2022 |
|
| Diagnosis of Idiopathic Environmental Intolerance |
CPCPLAB023 |
8/22/2022 |
|
| Epithelial Cell Cytology in Breast Cancer Risk Assessment |
CPCPLAB024 |
8/22/2022 |
|
| Fecal Analysis in the Diagnosis of Intestinal Dysbiosis |
CPCPLAB025 |
8/22/2022 |
|
| Fecal Calprotectin Testing |
CPCPLAB026 |
8/22/2022 |
|
| Testing for Diagnosis of Active or Latent Tuberculosis |
CPCPLAB027 |
8/22/2022 |
|
| Immune Cell Function Assay |
CPCPLAB028 |
8/22/2022 |
|
| Intracellular Micronutrient Analysis |
CPCPLAB029 |
8/22/2022 |
|
| In Vitro Chemoresistance and Chemosensitivities Assays |
CPCPLAB030 |
8/22/2022 |
|
| Measurement of Thromboxane Metabolites for ASA Resistance |
CPCPLAB031 |
8/22/2022 |
|
| Oral Screening Lesion Identification Systems and Genetic Screening |
CPCPLAB032 |
8/22/2022 |
|
| Diagnostic Testing of Influenza |
CPCPLAB033 |
8/22/2022 |
|
| Salivary Hormone Testing |
CPCPLAB034 |
8/22/2022 |
|
| Laboratory Testing for the Diagnosis of Inflammatory Bowel Disease |
CPCPLAB035 |
8/22/2022 |
|
| Biomarker Testing for Multiple Sclerosis and Related Neurologic Diseases |
CPCPLAB036 |
8/22/2022 |
|
| Serum Tumor Markers for Malignancies |
CPCPLAB037 |
8/22/2022 |
|
| Urinary Tumor Markers for Bladder Cancer |
CPCPLAB038 |
8/22/2022 |
|
| Vectra DA Blood Test for Rheumatoid Arthritis |
CPCPLAB039 |
8/22/2022 |
|
| ST2 Assay for Chronic Heart Failure |
CPCPLAB040 |
8/22/2022 |
|
| Erectile Dysfunction |
CPCPLAB041 |
2/15/2023 |
CPCLAB041v1 |
| ZIKA Virus Risk Assessment |
CPCPLAB042 |
8/22/2022 |
|
| Evaluation of Dry Eyes |
CPCPLAB043 |
8/22/2022 |
|
| Lyme Disease |
CPCPLAB044 |
8/22/2022 |
|
| Pathogen Panel Testing |
CPCPLAB045 |
8/22/2022 |
|
| Cardiac Biomarkers for Myocardial Infarction |
CPCPLAB046 |
8/22/2022 |
|
| Pancreatic Enzyme Testing for Acute Pancreatitis |
CPCPLAB047 |
8/22/2022 |
|
| Folate Testing |
CPCPLAB048 |
8/22/2022 |
|
| General Inflammation Testing |
CPCPLAB049 |
8/22/2022 |
|
| Urine Culture Testing for Bacteria |
CPCPLAB050 |
8/22/2022 |
|
| Diagnostic Testing of Common Sexually Transmitted Infections |
CPCPLAB051 |
8/22/2022 |
|
| Testing for Mosquito- or Tick-Related Infections |
CPCPLAB052 |
8/22/2022 |
|
| β-Hemolytic Streptococcus Testing |
CPCPLAB053 |
8/22/2022 |
|
| Parathyroid Hormone, Phosphorus, Calcium, and Magnesium Testing |
CPCPLAB055 |
8/22/2022 |
|
| Gamma-glutamyl Transferase |
CPCPLAB056 |
8/22/2022 |
|
| Coronavirus Testing in the Outpatient Setting |
CPCPLAB057 |
8/22/2022 |
|
| Venous and Arterial Thrombosis Risk Testing |
CPCPLAB058 |
8/22/2022 |
|
| Diagnosis of Vaginitis including Multi-target PCR Testing |
CPCPLAB059 |
8/22/2022 |
|
| Genetic Testing for Adolescent Idiopathic Scoliosis |
CPCPLAB060 |
8/22/2022 |
|
| Testing for Alpha-1 Antitrypsin Deficiency |
CPCPLAB061 |
8/22/2022 |
|
| Identification of Microorganisms using Nucleic Acid Probes |
CPCPLAB063 |
8/22/2022 |
|
| Nerve Fiber Density Testing |
CPCPLAB064 |
8/22/2022 |
|
| Plasma HIV-1 and HIV-2 RNA Quantification for HIV Infection |
CPCPLAB065 |
8/22/2022 |
|
| DNA Ploidy Cell Cycle Analysis |
CPCPLAB066 |
8/22/2022 |
|
| Testing of Homocysteine Metabolism-Related Conditions |
CPCPLAB067 |
8/22/2022 |
|
| Onychomycosis Testing |
CPCPLAB068 |
8/22/2022 |
|
| Immunohistochemistry |
CPCPLAB069 |
8/22/2022 |
|
| Prescription Medication and Illicit Drug Testing in the Outpatient Setting |
CPCPLAB070 |
8/22/2022 |
|
